RITA ZUBER: Open Payments
NPI 1720038003 · WEST MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,209 in 125 payments from 23 companies in 2025. Trend: 2023 $1,249 · 2024 $1,825 · 2025 $2,209
Food & beverage: $2,209
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $554 |
| ABBVIE INC. | 28 | $377 |
| Bayer Healthcare Pharmaceuticals Inc. | 12 | $178 |
| Axsome Therapeutics, Inc. | 11 | $166 |
| Novo Nordisk Inc | 13 | $164 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $151 |
| Otsuka America Pharmaceutical, Inc. | 4 | $95 |
| PFIZER INC. | 5 | $87 |
| Lilly USA, LLC | 4 | $64 |
| Abbott Laboratories | 3 | $61 |
Products named: BREZTRI, UBRELVY, Kerendia, FARXIGA, Auvelity, CAPLYTA, QULIPTA, REXULTI.
Industry payments across LA — which companies pay providers there.
